Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
Novartis to Invest US$23 Billion in Denton, Texas, USA
Novartis has announced plans to invest US$23 billion to establish a new radioligand therapy manufacturing facility in Denton, Texas
CSL to Invest US$1.5 Billion in Illinois, USA
CSL has announced an investment of US$15 billion to expand its plasmaderived therapies manufacturing facility in Kankakee, Illinois, USA
ESTEVE CDMO to Invest US$15.5 Million in Illinois, USA
ESTEVE CDMO has announced an investment of US$155 million to expand and upgrade its small molecule active pharmaceutical ingredient API manufacturing facility in Morton Grove, Illinois, USA
PharmaEssentia to Invest US$46 Million in Puerto Rico, USA
PharmaEssentia has announced an investment of approximately US$46 million to establish a new manufacturing facility in Toa Baja, Puerto Rico, USA
AbbVie to Invest US$380 Million in North Chicago, USA
AbbVie has announced an investment of US$380 million to construct two active pharmaceutical ingredient API manufacturing facilities at its North Chicago campus in Illinois, USA
Vetter Pharma to Invest US$530 million (€480 Million) in Saarlouis, Germany
Vetter Pharma has announced plans to invest approximately US$530 million 480 million in the first phase of a new commercial manufacturing facility in Saarlouis, Germany
Novo Nordisk to Invest over US$467 Million (€400 Million) in Athlone, Ireland
Novo Nordisk has announced plans to invest over US$467 million 400 million to expand its tablet manufacturing facility in Athlone, Ireland
Johnson & Johnson to Invest over US$1 Billion in Pennsylvania, USA
Johnson Johnson has announced an investment of over US$1 billion to develop a nextgeneration cell therapy manufacturing facility in Montgomery County, Pennsylvania, USA The development will support the production of advanced cell therapies used in the treatment of cancer
FUJIFILM Biotechnologies to Invest US$500 Million (£400 Million) in Teesside, United Kingdom
FUJIFILM Biotechnologies has announced an investment of approximately US$500 million 400 million to expand its biomanufacturing and process development facilities in Teesside, United Kingdom The development involves the expansion of biomanufacturing and process development facilities to support
Eli Lilly to Invest over US$3.5 Billion in Pennsylvania, USA
Eli Lilly and Company has announced plans to invest more than US$35 billion in a new injectable medicine and device manufacturing facility in Lehigh Valley, Pennsylvania, USA The development involves the construction of an injectable medicine and device manufacturing facility to support
